ARCHIVES

DCT Board Okays $3 Million In New Programs, $8 Million In Recompetitions

This article is from The Cancer Letter archive.

Vol. 06 No. 42 | October 24, 1980

Download PDF Visit The Full Archive

Related Articles

FDA Designates Zometa For Priority Review.

November 30, 2001

ACS President Huerta Disagrees With Staff On Cell Phone Danger.

August 1, 2008

American Association for Cancer Research Presents Awards at 2012 Annual Meeting

April 6, 2012

Fibrolast Interferon Contract Signed

May 2, 1980

Strategic Plan Identifies Goal; To Be The Authoritative Source For Cancer Information

May 21, 1999

Votrient Trial Meets PFS Endpoint In Epithelial Ovarian Cancer

June 28, 2013